Parkwalk Advisors — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
UK developer of 5G physical layer and channel coding IP for satellite non-terrestrial networks, spun out of the University of Southampton.
Co-investorsBloc VenturesIQ Capital
.jpeg){kind=logo}
Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another.
BiotechDeep TechHealthtech
Julian Gough(Co-founder)inOwen Rackham(Co-founder)inJose Polo(Co-founder)inDarrin M. Disley(CEO)in
BoardJane Osbourn(Chair)
Co-investorsAhren Innovation CapitalAstellas Venture Management LLC
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesDiamond Edge VenturesO2h VenturesWren Capital
Proxisense develops high-performance sensors for monitoring manufacturing processes and diagnostics, with origins in aerospace and defence applications.
Advanced ManufacturingDeep TechHardwareIoTMedical DevicesOxford, GB
Paul Vickery(Founder and Chairman)Kam Chana(Founder and NED)
Co-investorsFuture Planet CapitalOxford Science Enterprises
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.